BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19626356)

  • 1. Clinical perspective: monitoring sodium oxybate-treated narcolepsy patients for the development of sleep-disordered breathing.
    Feldman NT
    Sleep Breath; 2010 Feb; 14(1):77-9. PubMed ID: 19626356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.
    George CF; Feldman N; Inhaber N; Steininger TL; Grzeschik SM; Lai C; Zheng Y
    Sleep Med; 2010 Jan; 11(1):38-42. PubMed ID: 19897413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
    George CF; Feldman N; Zheng Y; Steininger TL; Grzeschik SM; Lai C; Inhaber N
    Sleep Breath; 2011 Jan; 15(1):13-20. PubMed ID: 20082240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J; Swick T; Bogan R; Lai C; Carter LP
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sodium oxybate (Xyrem in patients with dual diagnosis of narcolepsy and sleep apnea.
    Kovacević-Ristanović R; Kuźniar TJ
    Sleep Med; 2010 Jan; 11(1):5-6. PubMed ID: 19962938
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.
    Donjacour CE; Aziz NA; Roelfsema F; Frölich M; Overeem S; Lammers GJ; Pijl H
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1069-75. PubMed ID: 21447786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy.
    Dauvilliers Y; Roth T; Guinta D; Alvarez-Horine S; Dynin E; Black J
    Sleep Med; 2017 Dec; 40():53-57. PubMed ID: 29221779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
    Roth T; Thorpy MJ; Kushida CA; Horsnell M; Gudeman J
    J Comp Eff Res; 2023 Dec; 12(12):e230133. PubMed ID: 37971303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium oxybate for the treatment of fibromyalgia.
    Staud R
    Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
    Roth T; Dauvilliers Y; Thorpy MJ; Kushida C; Corser BC; Bogan R; Rosenberg R; Dubow J; Seiden D
    CNS Drugs; 2022 Apr; 36(4):377-387. PubMed ID: 35380374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis.
    Alshaikh MK; Tricco AC; Tashkandi M; Mamdani M; Straus SE; BaHammam AS
    J Clin Sleep Med; 2012 Aug; 8(4):451-8. PubMed ID: 22893778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium oxybate and sleep apnea: a clinical case.
    Hartley S; Quera-Salva MA; Machou M
    J Clin Sleep Med; 2011 Dec; 7(6):667-8. PubMed ID: 22171208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcolepsy--master of disguise: evidence-based recommendations for management.
    Mohsenin V
    Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REM Sleep Behavior Disorder in Children With Type 1 Narcolepsy Treated With Sodium Oxybate.
    Antelmi E; Filardi M; Pizza F; Vandi S; Moresco M; Franceschini C; Tinazzi M; Ferri R; Plazzi G
    Neurology; 2021 Jan; 96(2):e250-e254. PubMed ID: 33177222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing sodium oxybate for narcolepsy.
    Zeman A; Zaiwalla Z
    BMJ; 2016 Apr; 353():i2367. PubMed ID: 27126864
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
    Rosenberg R; Braceras R; Macfadden W; Candler S; Black J; Ruoff C
    Neurol Ther; 2023 Dec; 12(6):1805-1820. PubMed ID: 37755650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium oxybate-induced sleep driving and sleep-related eating disorder.
    Wallace DM; Maze T; Shafazand S
    J Clin Sleep Med; 2011 Jun; 7(3):310-1. PubMed ID: 21677903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls.
    Donjacour CE; Aziz NA; Frölich M; Roelfsema F; Overeem S; Lammers GJ; Pijl H
    Eur J Endocrinol; 2011 Mar; 164(3):363-70. PubMed ID: 21148631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem).
    Alshaikh MK; Gacuan D; George S; Sharif M; Bahammam AS
    Clin Neuropharmacol; 2011; 34(1):1-4. PubMed ID: 21206362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.